Redeye sees the acquisition announced yesterday at market close as a good step for Xvivo to broaden their product portfolio and, through synergies with the target companies, enable more significant market opportunities. The message of the share issue at zero discount sends a strong signal of trust in the Xvivo case. We will review our case with a positive bias on the back of this acquisition even though there will be a minor technical dilution effect at 7 percent due to the share issue.